Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05878405 · ClinicalTrials.gov registry record · Phase 3
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
NCT05878405: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT05878405 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05878405, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
Study Summary
This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compared to usual standard of care.
Interventions
- OTHER Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse
- OTHER Methylene Blue Oral Rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2024-12-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05878405
The ClinicalTrials.gov registry entry for NCT05878405 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse is the first listed.
NCT05878405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05878405 about?
NCT05878405 is a clinical study titled "Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer". This phase III trial compares the effect of methylene blue mouthwash to standard of care mouthwash for the treatment of oral mucositis pain in patients with cancer. Using methlylene blue mouthwash may improve oral pain in patients with oral mucositis related to cancer and/or cancer treatments compar...
What is the current status of trial NCT05878405?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2023-06-06. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT05878405?
The interventions under investigation include: Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse (OTHER), Methylene Blue Oral Rinse (OTHER).
Who is sponsoring clinical trial NCT05878405?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.